At the J.P. Morgan Health Care conference, the future outlook for GLP-1 drugs used to treat obesity was a key focus, ...
Should Australian investors ride market momentum or confront the risks of concentrated exposure to banks on the ASX and to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback